These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16363542)

  • 41. [Gastroduodenal lesions and non-steroidal anti-inflammatory agents. What role does Helicobacter pylori play in this relationship?].
    Gisbert JP; Boixeda D; Martín de Argila C; García Plaza A
    Rev Esp Enferm Dig; 1998 Sep; 90(9):655-64. PubMed ID: 9780802
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer.
    Gisbert JP; Khorrami S; Carballo F; Calvet X; Gene E; Dominguez-Muñoz E
    Aliment Pharmacol Ther; 2004 Mar; 19(6):617-29. PubMed ID: 15023164
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Should H. pylori infection in duodenal ulcer be confirmed before administering eradicating treatment?].
    Gisbert JP; Pajares JM
    Med Clin (Barc); 1999 Jul; 113(4):134-7. PubMed ID: 10472599
    [No Abstract]   [Full Text] [Related]  

  • 44. Effect of Helicobacter pylori eradication on ulcer recurrence after simple closure of perforated duodenal ulcer.
    El-Nakeeb A; Fikry A; Abd El-Hamed TM; Fouda el Y; El Awady S; Youssef T; Sherief D; Farid M
    Int J Surg; 2009 Apr; 7(2):126-9. PubMed ID: 19138577
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [What factors influence healing of duodenal ulcer when Helicobacter pylori eradication treatment is used?].
    Gisbert JP; Boixeda D; de Rafael L; Alvarez Baleriola I; Martín de Argila C; García M; García Plaza A
    Rev Esp Enferm Dig; 1996 Mar; 88(3):179-84. PubMed ID: 8645510
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Prevention of recurrence of duodenal ulcer by eradication of Helicobacter pylori. A major progress].
    Filoche B
    Rev Prat; 1993 Sep; 43(14):1827-9. PubMed ID: 8310227
    [No Abstract]   [Full Text] [Related]  

  • 47. [Non-ulcer dyspepsia (NUD) is one of the diseases for which H. pylori eradication is recommended].
    Suzuki K; Kuwayama H
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():288-96. PubMed ID: 16363547
    [No Abstract]   [Full Text] [Related]  

  • 48. [Effect of maintenance therapy by H2RA on the recurrence of gastric and duodenal ulcer and on the occurrence of reflux esophagitis, gastric erosions, and duodenal erosions after H. pylori eradication].
    Maeyama S; Yoshihara H; Kamada T; Kubota S; Kobayashi I; Tsuji S; Kawano S
    Nihon Rinsho; 2005 Nov; 63 Suppl 11():512-5. PubMed ID: 16363591
    [No Abstract]   [Full Text] [Related]  

  • 49. Does the eradication of Helicobacter pylori cure duodenal ulcer disease in communities with a high prevalence rate? Comparison with long-term acid suppression.
    Kepekci Y; Kadayifci A
    Int J Clin Pract; 1999; 53(7):505-8. PubMed ID: 10692734
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of screening for Helicobacter pylori in patients with duodenal ulceration in the primary health care setting.
    Rosengren H; Polson RJ
    Br J Gen Pract; 1996 Mar; 46(404):177-9. PubMed ID: 8731626
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Conference report: duodenal ulcer trials reported at the European Helicobacter pylori Study Group, Edinburgh 1995.
    Bell GD
    Aliment Pharmacol Ther; 1996 Feb; 10(1):49-54. PubMed ID: 8871443
    [TBL] [Abstract][Full Text] [Related]  

  • 52. What are appropriate end-points for Helicobacter pylori eradication in the treatment of duodenal ulcer?
    Williams MP; Pounder RE
    Drugs; 1998 Jul; 56(1):1-10. PubMed ID: 9664194
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Helicobacter pylori reinfection: what's the risk?
    Elta GH
    Gastroenterology; 1994 Nov; 107(5):1563-4. PubMed ID: 7926524
    [No Abstract]   [Full Text] [Related]  

  • 54. [Is there a relationship between the eradication of Helicobacter pylori and the disappearance of the symptoms?].
    Nadal Blanco MJ; Asensio Catalán MP; Palacios Rojo JJ
    Aten Primaria; 2002 Jun; 30(2):121-4. PubMed ID: 12106564
    [No Abstract]   [Full Text] [Related]  

  • 55. What can we learn from Helicobacter pylori reinfection in childhood?
    Gottrand F; Vincent P
    J Pediatr Gastroenterol Nutr; 2005 Mar; 40(3):276-8. PubMed ID: 15735479
    [No Abstract]   [Full Text] [Related]  

  • 56. More on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer.
    Schütze K; Hentschel E; Brandstätter G
    N Engl J Med; 1993 Oct; 329(18):1356. PubMed ID: 8413426
    [No Abstract]   [Full Text] [Related]  

  • 57. Diet and duodenal ulcer.
    Misciagna G; Cisternino AM; Freudenheim J
    Dig Liver Dis; 2000; 32(6):468-72. PubMed ID: 11057920
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vonoprazan: first global approval.
    Garnock-Jones KP
    Drugs; 2015 Mar; 75(4):439-43. PubMed ID: 25744862
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Duodenal bulb infection may be a risk factor for Helicobacter pylori eradication insuccess.
    Sirin G; Sezikli M; Eruyar AT; Dindar G; Dönmez E
    Eur J Gastroenterol Hepatol; 2021 Feb; 32(2):303-304. PubMed ID: 33369960
    [No Abstract]   [Full Text] [Related]  

  • 60. Pancreatic arteriovenous malformation associated with duodenal ulcer and H. pylori infection.
    Regenet N; Tuech JJ; Pessaux P; Aube C; Rousselet MC; Arnaud JP
    Int J Pancreatol; 2001; 29(2):113-6. PubMed ID: 11876248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.